Gabapentin (GBP), an analgesic, adjunct antiepileptic, and migraine prophylactic drug, reduces neuronal injury induced by cerebral ischemia reperfusion (IR). However, the underlying biological molecular mechanism of GBP neuroprotection is not clear. In this study, we confirmed that dose-dependent (75 and 150 mg/kg) GBP treatment could significantly reduce IR-induced neuronal death. IR-induced neuronal death was inhibited by pretreatment with 150 mg/kg GBP in a middle cerebral artery occlusion rat model. In addition, 150 mg/kg GBP treatment remarkably promoted the levels of antioxidants and reduced the autophagy of neurons in the infarct penumbra. Moreover, the phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway was activated by pretreatment with 150 mg/kg GBP, as detected by Western blot analyses. In vitro, pretreatment of PC12 cells with 450 mM GBP significantly reduced cell death induced by oxygen-glucose deprivation, increased antioxidant function, and reduced the levels of autophagy and reactive oxygen species via activation of the PI3K/Akt/mTOR pathway. This neuroprotection by GBP was inhibited significantly by 10 mM LY294002. In summary, dose-dependent pretreatment with GBP protected against cerebral IR injury via activation of the PI3K/ Akt/mTOR pathway, which provided a neuroprotective function to inhibit oxidative stress-related neuronal autophagy.
INTRODUCTION
As an acute brain blood circulation disorder, ischemic stroke has high incidence, morbidity, and mortality worldwide (1) (2) (3) . Neuronal injury triggers a complex series of pathophysiological events leading to cell death by numerous molecular pathways activated by transient cerebral ischemia. Recently, autophagy, as a mechanism of cell death, has attracted the attention of many researchers. Identification of the molecular pathways of autophagy in transient cerebral ischemia will contribute to the understanding of anti-autophagy and neuronal protection in transient cerebral ischemia.
Autophagy is an intracellular process involving the degradation and recycling of macromolecules and organelles (4, 5) . Autophagy may not only help promote cell survival but may also promote cell death through excessive self-digestion and degradation of essential cellular constituents (6, 7). A balanced level of autophagy is critically important for neuronal function (8) (9) (10) . The autophagy pathway can be stimulated by multiple forms of stress including nutrient or growth-factor deprivation, hypoxia, and reactive oxygen species (ROS) (11, 12) . ROS are classic autophagy inducers (13) . It is generally recognized that autophagy, a normal physiological process, participates in growth and development, apoptosis, metabolism, aging, and other cellular processes (14, 15) . In addition, autophagy is promptly activated during oxygenglucose deprivation (OGD) and cerebral ischemia (16) (17) (18) . At present, accumulating evidence indicates that modulation of autophagy may be used as a new drug target for the treatment of cerebral ischemia stroke (19, 20) .
Gabapentin (GBP) is commonly used clinically as an analgesic, adjunct antiepileptic, and migraine prophylactic drug. It exhibits antioxidant effects (21) , and antiseizure effects (22, 23) , and alters glutamate synthesis and metabolism (24) . Treatment with 50 mg/kg GBP attenuates hippocampal and cortical neurodegeneration in diabetic rats (21) . In addition, recent experimental studies have shown that 200 mg/kg GBP has neuroprotective effects against neuronal injury and reduces acute seizures induced by transient cerebral ischemia (25) , However, further studies are needed on the molecular mechanism of GBP's neuroprotection, particularly whether GBP can regulate autophagy and other related signaling pathways after cerebral ischemia reperfusion (IR). In this study, we investigated the effects of GBP on neurons after cerebral IR and the relationship between GBP's neuroprotective effect and autophagy regulated by GBP treatment.
MATERIALS AND METHODS

Experimental Animals
Male Sprague-Dawley rats (B.W., 220-250 g) were purchased from comparative medicine center of Yangzhou University (Yangzhou, China) and used after one week of acclimation. They were housed in a conventional state under adequate temperature (23 C) and humidity (60%) control with a 12-hour light/12-hour dark cycle, and free access to food and water. This study was carried out in accordance with the recommendations of the National Institutes of Health guidelines for the care and use of laboratory animals (Guide for the Care and Use of Laboratory Animals, the National Academies Press, 8th Ed., 2011). All of the experiments were conducted to minimize the number of animals used and the suffering caused by the procedures used in the present study. The animal protocol was approved based on ethical procedures and scientific care by the Yangzhou University-Institutional Animal Care and Use Committee (YIACUC-14-0014).
Transient Middle Cerebral Artery Occlusion
To induce transient cerebral ischemia, rats were initially anesthetized with 3%-4% isoflurane (RWD Life Science, Guangdong Province, China) in a 70% N 2 O-30% O 2 (v/v) mixture via a facemask. Anesthesia was maintained with 2.5% isoflurane. After skin preparation and disinfection with iodophor, an incision was made along the midline of the neck to expose the fascia, glands and muscles of the neck. Then the common carotid artery (CCA), external carotid artery (ECA), internal carotid artery (ICA), and vagus nerve were isolated. After ligating the distal end of the ECA, we then temporarily clamped the proximal end of the CCA and the distal end of the ECA with an arterial clamp. An ophthalmic scissors was used to cut a "V" incision in the ECA and pull down the ECA to align it with the ICA. A nylon monofilament suture (Beijing Cinontech Co. Ltd. 2432-A4; Beijing, China) was inserted into the stump of the ECA and advanced into the lumen of the ICA until it reached and occluded the middle cerebral artery (MCA). The distance from bifurcation of the CCA to the tip of the suture inserted to occlude the MCA averaged 18-20 mm. After 90 minutes of ischemia, the filament was withdrawn to initiate reperfusion. Sham operation groups were subjected to the same operation without inserting a monofilament. During surgery (i.e. insertion/removal of a filament to induce transient MCA occlusion [MCAO] /reperfusion in the carotid artery), all rats were kept at 37.0-37.9
C by means of an automated heating pad connected to a rectal thermometer to avoid rapid reduction in body temperature due to the anesthesia.
Drug Treatments
The animals were divided into 8 groups as follows (n ¼ 21 in each group): (i) control group; (ii) preGBP 75 mg/kg group (75 GBP group); (iii) preGBP 150 mg/kg groups (150 GBP group); and (iv) postGBP 150 mg/kg GBP group (p150 GBP group). Each group was then further divided into sham-operated and operated groups. All animals were killed at 1 day or 3 days after cerebral IR. GBP (Jiangsu Hengrui Pharmaceutical Co., Ltd, Jiangsu, China) was dissolved in 0.9% saline. GBP was administered intragastrically 30 minutes, 24 hours, and 48 hours before and after ischemic surgery. The presham group and pre-ischemia group received the same amount of 0.9% saline intragastrically for the same durations. Following the last administration, the rats underwent ischemia/reperfusion or sham operation.
TTC Staining and Quantification of Infarct Volume
At 1 day postreperfusion, the rats were anesthetized with 10% chloral hydrate (Aladdin, Shanghai, China) and underwent quick decapitation. The brains were carefully removed, weighed and sectioned coronally at 2-mm thickness. After staining with 2% 2, 3, 5-triphenyl tetrazolium chloride ([TTC] , Sigma-Aldrich, St. Louis, MO) for 0.5 hour at room temperature in the dark, the brain slices were fixed with 4% formalin at room temperature overnight. The viable part of brain slice was red while the dead part was pale white. The infarct areas and the whole area of each brain slice were measured using Image J software. The infarct volume was calculated by multiplying the added infarct areas of each slices by slice thickness (2 mm), and results were expressed as the ratio of (infarct volume/the whole brain volume) Â 100%.
Neurological Score
At 1 day after IR, the rats were tested for neurobehavioral score according to the Bederson scale (0-3) (26) as follows: Grade 0: no observable deficit; grade 1: forelimb flexion; grade 2: decreased resistance to lateral push (and forelimb flexion) without circling; grade 3: same behavior as grade 2 with circling. Blinded scoring was performed at the prescribed time. The standard model is established successfully when the scores are ! grade 1.
Tissue Processing for Histology
Tissues were collected as previously described (27) , animals were anesthetized with 10% chloral hydrate (Aladdin) and perfused transcardially with 0.1 M phosphate-buffered saline ([PBS], pH 7.4) followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The brains were removed and postfixed in the same fixative for 4 hours. The brain tissues were cryoprotected by infiltration with 30% sucrose overnight. Thereafter, frozen tissues were serially sectioned on a cryostat (Leica, Wetzlar, Germany) into 30-lm coronal sections and then collected into six-well plates containing PBS.
Cell Culture and Treatment
Rat pheochromocytoma-derived cell line PC-12 was purchased from American Type Culture Collection and maintained at 37 C in a humidified atmosphere containing 5% CO 2 . Cells were grown in Dulbecco's modified Eagle medium (DMEM) (Gibco, Grand Island, NY) with 5% heat-inactivated fetal bovine serum (Gibco) and 10% horse serum (Gibco), penicillin (100 U/mL), and streptomycin (100 mg/mL). As soon as they became stable, the cells were pretreated with GBP (TCI, Shanghai, China) and LY294002 (MCE MedChem Express, Monmouth, NJ), and then exposed to OGD after 24-hour pretreatment. Three different GPB concentrations (150, 300, and 450 mmol/L) were divided into either 10 mmol/L LY294002 group or no LY294002 group and exposed to OGD. The vehicle group was not treated with any drugs. Cell viability was measured using the Cell Counting Kit-8 (CCK8; Dojindo Laboratories, Kumamoto, Japan).
OGD Treatment
For OGD injury, PC12 cells were washed with PBS (pH 7.2) and then with glucose-free DMEM; the cells were kept in a hypoxic chamber (Thermo Fisher, Waltham, MA) containing 95% N 2 and 5% CO 2 for 6 hours. After OGD exposure, glucose solution was added and the cells were incubated (at 37 C in a humidified atmosphere containing 5% CO 2 ) for an additional 24 hours. After 24-hour reperfusion, whole cell lysates from PC12 prepared for Western blot analysis were generated using a Total Protein Extraction Kit (KeyGEN, Nanjing, China). The vehicle group was treated with the same amount of serum-free glucose DMEM and incubated.
CCK8 Cell Viability Assay
Cell viability was detected using the CCK-8 method. Briefly, cells were seeded into a 96-well plate at a density of 1 Â 10 5 cells/100 lL. As soon as they became stable, the cells were pretreated with GBP and LY294002 and then exposed to OGD for 24 hours. After 24-hour reperfusion, 10 mL CCK8 solution was added to each well (100 mL medium), incubated for 2 hours at 37 C, and then the absorbance was measured at 450 nm in a Multimode Plate Reader (Espier, PerkinElmer, Singapore).
ROS Assay
ROS levels were measured using the probe 2 0 , 7 0 -dichlorofluorescein diacetate (DCFH-DA). DCFH-DA (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) was diluted 1:1000 with serum-free medium to a final concentration of 10 lM. After the PC12 cells were subjected to OGD and reperfusion, the original culture medium was removed and each dish was filled with at least 1 mL diluted DCFH-DA to fully cover the cells. After a 20-minute incubation of the cells at 37 C, 200 mL the incubation medium was extracted and the extracellular ROS levels were determined by measurement of the fluorescence of DCFH-DA (excitation and emission wavelengths 488 and 525 nm, respectively) using the Jasco FP-750 spectrofluorometer. To minimize the lightinduced decomposition of DCFH-DA, all experimental procedures were performed in the dark.
Immunohistochemistry
Immunohistochemistry was performed out according to a previously published procedure (27) . The sections were sequentially treated with 0.3% hydrogen peroxide (H 2 O 2 ) in PBS for 20 minutes and 5% normal serum in 0.01 M PBS for 30 minutes. The sections were next incubated with diluted rabbit antiGFAP (1:500, Abcam, Cambridge, UK), goat anti-Iba1 (1:500, Abcam), and rabbit antiNeuN (1:1000, Cell Signaling Technology, Danvers, MA) overnight at 4 C. Thereafter the sections were exposed to biotinylated goat antirabbit or rabbit antigoat IgG (1:250, Vector, Burlingame, CA) and streptavidin peroxidase complex (1:200, Vector) and visualized with 3, 3 0 -diaminobenzidine tetrahydrochloride in 0.01 M PBS and mounted on the Adhesion Microscope slides. After dehydration the sections were mounted in neutral balsam (Solarbio, Beijing, China). In order to establish the specificity of the immunostaining, a negative control test was carried out with pre-immune serum instead of primary antibody. The negative control resulted in the absence of immunoreactivity in all structures. The staining intensity of GFAP, Iba1 and NeuNimmunoreactive structures was evaluated on the basis of an optical density (OD), which was obtained after the transformation of the mean gray level using the formula: OD ¼ log (256/ mean gray level). The OD of background was taken from areas adjacent to the measured area. After the background density was subtracted, a ratio of the OD of image file was calibrated as % (relative OD) using Adobe Photoshop version 8.0, and then analyzed using NIH Image 1.59 software. We normalized each sample against the level of vehicle-sham sample. In order to ensure objectivity all measurements were performed under blind conditions by 2 observers for each experiment under the same conditions.
Immunofluorescence
Brain sections were rinsed with PBS twice, permeabilized with 0.5% Triton X-100 for 10 minutes, and then blocked with PBS containing 0.2% Triton X-100 and 5% BSA for 1 hour at room temperature. Then the brain sections were incubated with the following primary antibodies: Rabbit-antiLC3B (1:500; Abcam); mouse-antiNeuN (1:1000; Abcam); mouseantiBeclin-1 (1:400; Santa Cruz Biotechnology, Dallas, TX); and rabbit-antiNeun (1:100; Cell Signaling Technology) in a humidified container at 4 C for 16 hours. The sections were rinsed twice in PBS and sequentially incubated with the following secondary antibodies: Texas red-conjugated goat antimouse IgG (1:400, Abcam) and fluorescein isothiocyanate-conjugated goat antirabbit IgG (1:400, Abcam) in a humidified lucifugal container for 2 hours. The sections were washed twice in PBS and sealed using SHUR/Mount medium (Ted Pella Inc., Redding, CA) and the slides were analyzed by fluorescence microscopy (Nikon D-Eclipse C1; Tokyo, Japan).
Western Blot Analysis
Western blot analysis was performed out according to a previously published procedure (27) . After killing the rats (n ¼ 7 in each group), the brains were removed and serially and transversely cut into a thickness of 400 lm on a vibratome. The designation of the penumbral regions was based on numerous pharmacological and histopathological studies by Ashwal et al and others that have defined the adjacent ventrolateral cortex as the penumbra (28) (29) (30) . In brief, the brain of each animal was sectioned into 3 slices beginning 2 mm from the anterior tip of the frontal lobe (28) . Section two (4-mm thick) was used for the measurement of Western blot analysis. First, a longitudinal cut (from top to bottom) $2 mm from the midline between the 2 hemispheres was made to avoid mesial hemispheric structures, which are supplied primarily by the anterior cerebral artery. Next, the penumbras (adjacent cortex) were separated by a transverse diagonal cut at $30 from the vertical position. The whole cell lysates from PC12 and the brain tissue were preprocessed by Whole Cell Lysis Assay kit (KeyGEN)/Total Protein Extraction Kit. Protein concentrations were determined using a Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL). Equal amounts of protein (30 lg) were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (Millipore, Bedford, MA). In order to incubate antibodies, the same nitrocellulose membranes striped were used. To reduce background staining, the membranes were incubated with 5% BSA in TBS containing 0.1% Tween 20 for 60 minutes, followed by incubation with primary antibody overnight at 4 C and subsequently exposed to the corresponding secondary antibody for 2 hours at room temperature and the SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific) was used for protein detection. The result of Western blot analysis was scanned and densitometric analysis for the quantification of the bands was done using Quantity One Analysis Software (Bio-Rad, Hercules, CA), which was used to count relative OD: A ratio of the relative OD was calibrated as a percentage, with sham group designated as 100%. Each blot shown is representative of at least 3 similar independent experiments. The primary antibodies were listed as follows: Rabbit antiSOD1 
Statistical Analysis
The data shown here represent the means 6 standard error of the mean (SEM). Statistical analysis was carried out by using Student two-tailed t-test for comparison between 2 groups and one-way analysis of variance followed by Dunnett's test when the data included 3 or more groups. Statistical significance was considered at p < 0.05.
RESULTS
Effects of GBP on
TTC staining was used to evaluate the infarct volume after cerebral ischemia. In the group pretreated with 75 mg/kg GBP (75 GBP group), the sizes of the infarcts ($23% of the brain volume) were significantly decreased compared with those of the control MCAO group ($47% of the brain volume) (Fig. 1A, B) . In the group pretreated with 150 mg/kg GBP (150 GBP group), only a few small infarcts ($8% of the brain volume) were observed (Fig. 1A, B) . Moreover, we evaluated the neurological function of the rats according to the Bederson scale (0-3). The rats in the 150 GBP group obtained better scores (neurological function of 1) than those in the MCAO group (neurological function of 3; Fig. 1C ). These results indicate that GBP pretreatment decreased the infarct volume and ameliorated the neurological deficits of rats after IR, and that neuroprotection by GBP was particularly evident in the 150 GBP group. In the group pretreated with 150 mg/kg GBP, the sizes of the infarcts ($13% of the brain volume) were still significantly decreased compared with those of the MCAO group ($48% of the brain volume), which suggested that the GBP had persistently neuroprotective effects on neuronal damage induced by cerebral ischemia (Fig. 1D, E) . Meanwhile, we observed whether posttreatment of GBP also play a neuroprotective role in cerebral ischemia was observed by TTC. In the group posttreated with 150 mg/kg GBP, the sizes of the infarcts ($42% of the brain volume) were not significantly decreased compared with those of the MCAO group ($48% of the brain volume; Fig. 1F, G) , which suggested that posttreatment of GBP had no neuroprotective effect on neuronal damage induced by cerebral IR. Therefore, we focused on the neuroprotective mechanisms of pretreatment with GBP.
Effects of GBP on Changes in NeuN-positive Cells After 1 Day of Cerebral IR
NeuN-positive neurons were easily observed in the cerebral cortex and showed no significant differences in each sham group ( Fig. 2A-a, C-c, E-e, G) . However, the number of NeuN-positive neurons in the cerebral cortex after pretreatment with GBP was markedly increased compared with the MCAO group. Furthermore, the high-dose GBP pretreatment gave better neuroprotection than the low-dose pretreatment (Fig. 2B-b, D-d, F-f, G) . These results indicate that GBP pretreatment decreased the damage to neurons in the cerebral cortex after 1 day of cerebral IR. In addition, GBP pretreatment caused no side effects in normal animals.
Effects of GBP on Changes in Autophagy-and Apoptosis-Related Proteins in the Penumbral Region After 1 Day of Cerebral IR
A growing number of studies have focused on the function of autophagy during cerebral IR. In this study, we measured the levels of autophagy-related proteins (Fig. 3A-E) . The LC3-II/LC3-I protein ratio and levels of Beclin-1 and Atg5 were markedly decreased in the GBP-pretreated groups, particularly in the 150 GBP group, compared with the control MCAO group. In addition, we detected Bcl2 and cleaved-caspase3 protein levels to confirm the relationship between autophagy and apoptosis. The level of cleavedcaspase3 was markedly decreased in the GBP-pretreated groups compared with the control MCAO group, which had obviously increased levels compared with the sham group (Fig. 3F-H) . Similarly, the level of Bcl2 was markedly increased in the GBP-pretreated groups compared with the MCAO group. These data suggest that pre-ischemia GBP treatment may reduce neuronal apoptosis after cerebral IR by inhibiting autophagy.
Effects of GBP on Changes in Autophagosomes Accumulated in Neurons of the Penumbral Region after 1 Day of Cerebral IR
We used double staining to further clarify the effects of GBP on the number of autophagosomes accumulated in neurons of the penumbral region. As shown in Supplementary Data Figures S1 and S2, the number of NeuN-positive neurons in the penumbral region after pretreatment with GBP was markedly increased compared with that in the MCAO group. Double staining with NeuN and Beclin-1 demonstrated a certain level of Beclin-1 in neurons of the sham group. However, Beclin-1 was almost exclusively expressed in neurons in the penumbral region after IR, which suggests that the percentage of Beclin-1 expression in neurons significantly increased after IR. The level of Beclin-1 in neurons was markedly decreased in the 150 GBP group compared with the control MCAO group. Double staining with NeuN and LC3 indicated changes in the levels of LC3 similar to the changes in Beclin-1 levels. These results suggest that the number of autophagosomes in neurons of the penumbral region were decreased significantly in the 150 GBP group.
Effects of GBP on Changes in Glial Cells in the Penumbral Region After 1 Day of Cerebral IR
ROS are classic inducers of autophagy, and glial cells including astrocytes and microglia respond to the oxidative insult by gliosis. Glial cells (astrocytes and microglia) were activated in the infarction penumbra region in the MCAO group (Figs. 4, 5) . Gliosis, which is involved in the repair and regeneration of damaged neurons, is frequently increased in astrocytes and microglia in the penumbral region after cerebral IR. We observed that GBP administration dramatically decreased the activation of astrocytes and microglia after cerebral IR and had no significant influence on the sham group. These results suggest that GBP pretreatment decreases gliosis of astrocytes and microglia in the penumbral region after 1 day of cerebral IR. Thus, pretreatment with GBP can reduce the degree of neuronal damage after cerebral IR. 
Effects of GBP on Changes in Antioxidant Levels in the Penumbral Region After 1 Day of Cerebral IR
Endogenous antioxidant proteins play a major role in defending against ROS. To evaluate the changes in antioxidant levels in each group, the levels of superoxide dismutase (SOD), catalase and glutathione peroxidase 1 (GPX-1) were detected using Western blot analyses (Fig. 6A-E) . The levels of all of the antioxidant proteins, particularly catalase, were markedly increased in the penumbral region in the GBPpretreated groups compared with those in the MCAO group 1 day after IR. Their levels were also increased in the 150 mg/ kg GBP-pretreated group 3 days after IR (Fig. 7A) . Furthermore, the antioxidant ability of the 150 GBP group was greater than that of the 75 GBP group. These results suggest that GBP treatment enhances the antioxidative capacity of neurons after cerebral IR.
Role of PI3K/Akt/mTOR Signaling-Related Protein Levels in Brain Injury Induced by Cerebral IR
To investigate the possible mechanisms by which GBP ameliorated neuronal damage after cerebral IR, we used Western blot analyses to reveal related protein expression. As is well known, the phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway plays a vital regulatory role in autophagy and apoptosis following neuronal damage after IR. The level of PI3K was significantly increased in the penumbral region of the GBP-pretreated groups 1 day after IR compared with that of the control MCAO group (Fig. 6F-I) . Variation in the p-AKT/AKT and p-mTOR/ mTOR protein ratios was consistent with the change in the PI3K protein level. Moreover, we observed the levels of related protein in the PI3K/Akt/mTOR pathway were increased in 3 days after IR by pretreatment of 150 mg/kg GBP compared with those in the MCAO group (Fig. 7B) . These data suggested that GBP pretreatment protected against IR injury is related to activation of the PI3K/Akt/ mTOR pathway.
Cell Viability and the Level of Cleaved-Caspase3 of OGD/R-Injured PC12 Cells After GBP and LY294002 Pretreatment
The OGD model was used in vitro in PC12 cells. The neuroprotective effects of GBP on OGD/R injury were examined using the CCK8 assay and the level of cleavedcaspase3. Cell viability significantly reduced in the OGD group compared with the sham group (Fig. 8A) . However, the cell viability increased in the group pretreated with 450 mM GBP. In the group pretreated with both 450 mM GBP and 10 mM LY294002, the cell viability was markedly decreased compared with that in the group pretreated with only 450 mM GBP. Moreover, we further observed the levels of cleaved-caspase3 in the PC12 cells under OGD/R. The level of cleaved-caspase3 significantly increased in the OGD/R group compared with that in the sham group and was gradually decreased in the GBPtreated OGD/R group with dose-dependent GBP concentration (Fig. 8B, C) . However, both the protective effect of GBP and decreased level of cleaved-caspase in PC12 cells under OGD/R were inhibited by 10 mM LY294002 treatment. These results suggest that a dose of 450 mM GBP is sufficient to significantly reduce OGD/R injury, and that the neuroprotective effects of GBP are inhibited by LY294002. The Protein Levels of LC3-I/II, Beclin-1, Atg3, and Atg5 in OGD/R-Injured PC12 Cells Following GBP and LY294002 Pretreatment OGD/R significantly increased the levels of Beclin-1, Atg5, and Atg3, as well as the ratio of LC3-II/LC3-I (Fig. 8C-G ). After pretreatment with 450 mM GBP, the ratio of LC3-II/ LC3-I and the levels of Beclin-1 and Atg5 were markedly decreased. These effects of GBP were inhibited when 10 mM LY294002 was included in the pretreatment. The level of Atg3 barely changed after pretreatment with 450 mM GBP with or without 10 mM LY294002. Pretreatment with 450 mM GBP may have significantly reduced the autophagy, but the lack of effect on Atg3 may indicate involvement of the PI3K pathway or its downstream signaling pathway.
Levels of Antioxidant Enzymes and ROS in OGD/R-Injured PC12 Cells Following GBP and LY294002 Pretreatment
The levels of SOD2, catalase, and GPX-1 were markedly decreased in vitro after OGD/R (Figs. 8B, 9A-E) . The levels of ROS significantly increased after OGD/R as detected by the DCFH-DA assay. However, the decrease in antioxidant enzymes and increase in ROS induced by OGD/R were ameliorated by pretreatment with 450 mM GBP, particularly in the case of catalase. These effects of GBP on the levels of catalase, SOD1, and ROS were inhibited when 10 mM LY294002 was included in the pretreatment. These effects of GBP on antioxidant enzymes, particularly catalase, and their inhibition by LY294002 suggest that GBP affects the PI3K pathway.
PI3K/Akt/mTOR Signaling-Related Protein Levels in OGD/R-Injured PC12 Cells Following GBP and LY294002 Pretreatment
The levels of PI3K and ratios of p-AKT/AKT and p-mTOR/mTOR were significantly increased in the group pretreated with 450 mM GBP compared with the OGD group. However, these increases were inhibited by 10 mM LY294002 (Fig. 9F-I) . Together with the abovementioned results, these results suggest that pretreatment with GBP protects against autophagy by increasing the level of catalase via activation of the PI3K/Akt/mTOR pathway.
DISCUSSION
Ischemic stroke, a leading cause of death and severe disability, is a frequent central nervous system disorder with a poor prognosis. In this study, we used the rat MCAO model, which has been extensively accepted by numerous researchers and applied to discover prospective interventions and possible related mechanisms of cerebral ischemia. We confirmed that pretreatment with 75 mg/kg and 150 mg/kg GBP could significantly alleviate infarct volume and its concomitant impairment of neurological function after cerebral IR, consistent with previous studies (23, 25, 31) . Furthermore, we found that dose-dependent administration of GBP significantly improved the score of neurological function. We further explored the mechanism by which GBP protects against neuronal death induced by cerebral ischemia.
Autophagy is promptly activated by OGD during cerebral ischemia (16) (17) (18) . In the process of autophagy, several autophagy factors such as LC3, Beclin-1, Atg5, and Atg3 regulate the progress and duration of autophagy (32) (33) (34) . He et al reported that the neuronal damage or death induced by excessive autophagy after cerebral ischemia is related to the increase in levels of LC3-II and Beclin-1 (32) . In this experiment, both 75 and 150 mg/kg GBP pretreatment remarkably mitigated upregulated expression of Beclin-1, Atg5, Atg3, and the ratio of LC3 II/LC3 I induced by cerebral ischemia, which indicates that GBP administration can inhibit the increase in autophagy-related proteins induced by cerebral ischemia to ameliorate the cerebral ischemia-induced neuronal injury. In addition, Bcl-2 family proteins are pivotal moderators of apoptosis and autophagy. Anti-apoptotic protein Bcl-2 can be combined with Beclin-1 to directly regulate apoptosis and autophagy. Binding of Bcl-2/Bcl-XL complex to Beclin-1 inhibits autophagy (35) (36) (37) . Cleaved-caspase3, an activated form of caspase3, is the vital factor that promotes apoptosis. In this study, dose-dependent pretreatment with GBP markedly increased the protein expression of Bcl2 and decreased the level of cleaved-caspase3. Taken together, these results strongly suggest that dose-dependent GBP treatment protects against neuronal injury induced by cerebral IR through inhibition of pathways associated with autophagy-related cell death. Many researchers have shown that autophagy pathways can be stimulated by ROS (11, 12) . ROS, as key molecules in the crosstalk between apoptosis and autophagy, lead to irreversible cellular damage (38) . Endogenous antioxidant proteins play a major role in defending against ROS (39, 40) . Many drugs that increase expression of endogenous antioxidant proteins have been shown to conspicuously reduce damage to neuronal cells and brain tissue (41, 42) . Our study demonstrated that administration of both 75 and 150 mg/kg GBP significantly raised the levels of endogenous antioxidant proteins, including SOD, CAT, and GPX-1. One of the main mechanisms regarding the death of neurons by cerebral IR injury is oxidative stress caused by overproduction of ROS or intracellular oxidants (43) . GBP, a neuroprotector, showed an antioxidant effect against the neurodegeneration observed in rats with diabetes mellitus. Previously described studies have indicated that many drugs, including the antioxidants vitamin E and melatonin, ameliorated reactive gliosis and reduced the levels of ROS induced by cerebral ischemia via a dramatic reduction in oxidative stress (21, 44) . Free radicals actively attack macromolecules within glial cells resulting in structural and functional changes and glial cells, including astrocytes and microglia, respond to the oxidative insult by gliosis (21, FIGURE 7 . Effect of Gabapentin pretreatment on the changes of antioxidants and PI3K/Akt/mTOR pathway-associated proteins after 3 days cerebral IR. Changes of antioxidant levels (SOD-1, SOD-2, catalase and GPX-1) (A); Western blot of PI3K/AKT/mTOR signaling pathway protein (B). The result suggested that pretreatment of 150 mg/kg Gabapentin could persistently increase the levels of antioxidants and activated the PI3K/Akt/mTOR pathway to improve the neuronal damage after 3 days reperfusion. (n ¼ 7 per group; *p < 0.05, significantly different from the MCAO group). Bars indicate the means 6 SEM. 45). Previous reports have shown that gliosis occurred in neurodegenerative diseases as a result of oxidative stress (46) . In this study, we also found that GBP pretreatment significantly reduced both astrocyte and microglia reactive gliosis induced by transient cerebral ischemia. Therefore, our results demonstrate that dose-dependent pretreatment with GBP (75 and 150 mg/kg) increases the levels of endogenous antioxidants and decreases reactive gliosis to eliminate ROS, thereby ameliorating the cerebral ischemia induced neuronal autophagy.
The PI3K/Akt signaling pathway is essential to the growth and survival of neurons after cerebral ischemia. The activation of Akt, by controlling multiple intracellular signals, can inhibit neuronal autophagy and promote neuronal proliferation and survival (47, 48) . Many studies have reported that oxidative stress-induced neuronal damage and death after cerebral ischemia can be inhibited by activation of the PI3K/Akt signaling pathway (49, 50) . In this study, dose-dependent pretreatment with GBP protected against cerebral ischemia injury and protected neurons from oxidative stress by activating the PI3K/Akt signaling. Furthermore, mTOR, the downstream component of PI3K/Akt signaling, plays a crucial role in the process of autophagy (17, 51) . The mTOR pathway plays a key negative regulatory role in autophagy (52, 53) . Previous reports have shown that many drugs that upregulate phosphorylation of mTOR via activation of the PI3K/Akt pathway inhibit autophagy induced by cerebral IR (11, 47, 49) . In this study, we found that dose-dependent pretreatment with GBP upregulated p-mTOR protein levels and downregulated autophagy-related protein levels. In addition, LY294002 is a protein kinase inhibitor that blocks the signal transduction pathway of PI3K and it is widely used in the characteristic research of PI3K cell signaling pathways. Previous studies used LY294002 as PI3K inhibitor (54, 55) . Meanwhile, LY294002 is a nonspecific inhibitor that could influence many other pathways (56) , which means that GBP not only activated the PI3K/AKT pathway but also might activate the other pathway to display its neuroprotective function. GBP showed an antiinflammatory effect on inhibiting the action of various inflammatory cytokine, neutrophil infiltration and oxidative stress (57, 58) . Previous study already reported that GBP is mediated in the antidepressant model through nitric oxide/cyclic guanosine monophosphate pathway (59) . The protective effect of GBP was involved to the GABAergic mechanisms and their antioxidant-like effect, and GBP could reduce the activity of the Na þ or K þ channels (23, 60, 61) . In addition, Kumar et al reported that protective effect of GBP against oxidative damage involved to GABAergic modulation in mice (61) . Therefore, GBP could activate many different signaling cascades to induced anti-inflammatory and anti-oxidant effects. In the present study, we found GBP could improve the neuronal damage, antioxidants levels and gliosis following the ischemic stroke that may be related to activating the PI3K/AKT pathway. Meanwhile, activation of the PI3K/Akt/mTOR signaling pathway and the increased expression of CAT were both reduced, and the level of autophagy markedly increased after pretreatment with LY294002. Therefore, our results also demonstrate that dose-dependent pretreatment with GBP inhibits the cerebral ischemia induced neuronal autophagy via activation of the PI3K/Akt/mTOR pathway in neurons.
In summary, our study demonstrated that GBP pretreatment protects against cerebral IR injury, developing its neuroprotective function via activation of the PI3K/Akt/mTOR pathway to increase the antioxidant capacity and inhibit the oxidative stress-related autophagy.
